BriefCase-Quantification vs Imbio PHA (4.0.0)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BriefCase-Quantification

by Aidoc Medical

Imbio PHA (4.0.0)

by Imbio

AI Verdict

Tool A is designed for automated abdominal aortic diameter measurements from CT scans, assisting in general clinical decision-making. In contrast, Tool B focuses on cardiac structure measurements from CT pulmonary angiograms to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. While both are FDA-cleared AI tools for cardiovascular imaging, their specific anatomical targets and primary clinical applications differ.

Choose BriefCase-Quantification if…

Choose BriefCase-Quantification if your primary need is automated and accurate measurement of abdominal aortic diameters from CT scans. This tool is ideal for radiologists focused on efficiently assessing aortic health and streamlining workflows related to abdominal aortic aneurysm surveillance and management.

View BriefCase-Quantification →

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if you require automated, comprehensive cardiac measurements from CT pulmonary angiogram (CTPA) scans. This tool is particularly well-suited for assessing right ventricular dilation and aiding in the diagnosis and risk stratification of patients with suspected pulmonary embolism or hypertension.

View Imbio PHA (4.0.0) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BriefCase-Quantification	Imbio PHA (4.0.0)
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud-based	Cloud, Enterprise (on-premise), or via partners
FDA Status	1 AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Imbio PHA (4.0.0)

Imbio PHA emphasizes a fully automated process with no new user interfaces to learn, delivering results directly into existing PACS or a web-based portal, which streamlines the radiologist's workflow. This approach minimizes disruption and training overhead, making it highly usable within established clinical environments.

Clinical Value

Tie

Both tools are FDA-cleared and provide critical quantitative measurements that aid in the diagnosis and risk stratification of distinct, serious medical conditions. Both have demonstrated clinical accuracy through validation studies, making their respective clinical values high within their specialized areas. [cite: JSON, 11, 16, 28, 30]

Pricing & Value

BriefCase-Quantification

While both require direct contact for pricing, Tool A explicitly offers flexible financing options through partners like Capchase, allowing for monthly or multi-year installments. [cite: JSON, 9] This transparency and flexibility in payment can provide significant financial value and ease of adoption for healthcare providers.

Enterprise Readiness

Imbio PHA (4.0.0)

Imbio PHA offers superior enterprise readiness due to its flexible deployment options, including cloud, on-premise, or through partners. [cite: JSON, 31] This adaptability caters to a wider range of institutional IT policies and preferences, particularly for those requiring in-house data solutions.

Innovation

BriefCase-Quantification

Aidoc's BriefCase-Quantification is part of its comprehensive aiOSu2122 enterprise AI platform, which signifies a broader innovative ecosystem and strategic approach to AI in healthcare. Aidoc also demonstrates innovation in responsible AI by adopting CHAI Model Cards for transparency, which is a key emerging standard.

Support & Docs

BriefCase-Quantification

Aidoc offers a comprehensive 'Customer Success' program that includes training, educational content, performance tracking, and support for clinical research, alongside an extensive 'AI Learning Center' with various resources. This proactive and holistic approach to support and documentation, coupled with 24/7 support, provides a stronger offering for long-term user enablement and success.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BriefCase-Quantification	Imbio PHA (4.0.0)
Name	BriefCase-Quantification	Imbio PHA (4.0.0)
Company	Aidoc Medical	Imbio
Description	FDA-cleared AI tool for radiologists, providing automated abdominal aortic diameter measurements from CT scans to assist clinical decision-making and streamline workflows.	FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.
Key Features	Automated abdominal aortic diameter measurement, Radiological image management and processing, Integration with image review software, Cloud-based deployment, Assists medical specialists with quantitative measurements, Part of Aidoc's aiOSu2122 enterprise AI platform, Supports streamlined clinical workflows	Automated measurement of right and left ventricle diameters, Automated measurement of main pulmonary artery and aorta diameters, Calculates RV/LV and PA/Ao ratios, Utilizes artificial intelligence algorithms for anatomical identification and measurement, Generates annotated DICOM images, Provides summary reports in PDF format, Integrates with native DICOM tools and workflows, Rapid, fully-automated assessment (typically in minutes)
Specialties	Cardiology, Radiology, Vascular Surgery	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring BriefCase-Quantification and Imbio PHA (4.0.0).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of each tool?

Aidoc's BriefCase-Quantification is an FDA-cleared AI tool that provides automated abdominal aortic diameter measurements from CT scans to assist clinical decision-making and streamline workflows. Imbio PHA (4.0.0) is an FDA-cleared AI-powered software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.

What specific quantitative measurements do these AI tools provide?

BriefCase-Quantification provides automated abdominal aortic diameter measurements. Imbio PHA (4.0.0) automatically measures right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios.

What types of imaging studies are compatible with each tool?

BriefCase-Quantification is intended for use in the analysis of non-cardiac-gated non-contrast CT (NCCT) images that include the heart in adult patients aged 30 and older, specifically for abdominal aortic diameter measurements. Imbio PHA (4.0.0) specifically processes CT pulmonary angiogram (CTPA) scans.

How do these tools integrate into existing clinical workflows and present their results?

BriefCase-Quantification integrates with image review software and is part of Aidoc's aiOSu2122 enterprise AI platform, supporting streamlined clinical workflows. Imbio PHA (4.0.0) generates annotated DICOM images and provides summary reports in PDF format, integrating with native DICOM tools and workflows.